Global Heart Closure Devices Market Size study & Forecast, by Closure Type (Congenital Heart Defect Closure, PFO Closure, LAA Closure) and Regional Analysis, 2022-2029

Global Heart Closure Devices Market Size study & Forecast, by Closure Type (Congenital Heart Defect Closure, PFO Closure, LAA Closure) and Regional Analysis, 2022-2029

Global Heart Closure Devices Market is valued at approximately USD 2.05 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.9% over the forecast period 2022-2029. Heart closure devices is a type of medical device that is specially designed for the diagnosis and treatment of congenital heart defects such as ventricular septal defect, atrial septal defect, left atrial appendage defect, and patent ductus arteriosus. These illnesses affect the heart structure, which results in reducing the heart's ability to pump blood normally. Congenital heart abnormalities are treated by using closure devices to seal a gap between the right and left sides of the heart. Factors such as strong clinical evidence surrounding the device, the rising adoption of high-priced technologies expanded options for reimbursement, and the increase in adoption of MRI procedures are contributing to the market growth around the world.

The rising incidences of congenital heart disease (CHD) among the population are directly associated with the demand for heart closure devices in the global market. The Indian Pediatrics reported that almost 1.35 million babies are born with CHD each year globally. Likewise, according to The Centers for Disease Control and Prevention, it was estimated that CHD affected approximately 1% or nearly 40,000 births per year in the United States. Also, around 1 in 4 babies with a CHD have a critical CHD, which requires surgery or other procedures in their first year of life. Therefore, the high disease burden is stipulating the growth of the global market. Moreover, the increasing number of hospitals & surgical centers, as well as the rising development of innovative products by key players are presenting various lucrative opportunities over the forecasting years. However, the shortage of highly skilled professionals and stringent regulatory frameworks are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Heart Closure Devices Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing number of clinical trials, along with the rising government initiatives and high R&D investments. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising development of stronger healthcare infrastructure, increasing population, as well as rising prevalence of target disease in the market space.

Major market players included in this report are:
Abbott
W. L. Gore & Associates, Inc.
Boston Scientific Corp.
Occlutech
Heartstitch
SMT
Cardia, Inc.
Lifetech Scientific Corp.
Lepu Medical Technology (Beijing)Co., Ltd.
AtriCure Inc.

Recent Developments in the Market:
 In 2021, Vivasure Medical Ltd. (Ireland) declared the development of its product, PerQseal Blue. This product is a large-bore vascular closure device that is specially designed to be use after interventional cardiovascular procedures.

Global Heart Closure Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Closure Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:

By Closure Type:
Congenital Heart Defect Closure
PFO Closure
LAA Closure

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World


Companies Mentioned

Abbott
W. L. Gore & Associates, Inc.
Boston Scientific Corp.
Occlutech
Heartstitch
SMT
Cardia, Inc.
Lifetech Scientific Corp.
Lepu Medical Technology (Beijing)Co., Ltd.
AtriCure Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.